Literature DB >> 2246149

Segmental vascular resistance in postobstructive pulmonary vasculopathy.

R P Michel1, T S Hakim, D Petsikas.   

Abstract

Chronic unilateral pulmonary arterial ligation has been touted as a model of arteriopathy resulting in a tremendous increase in anastomotic bronchial flow (Qbr) via collaterals. To investigate its effects on the pulmonary vasculature, we ligated the left main pulmonary artery of seven dogs and 120 days later pump perfused their left lower lobes (LLL) via a cannula in the pulmonary artery at pulmonary arterial flow (Qpa) of 250 ml/min. We measured Qbr (330 ml/min) and compared LLL with control contralateral right lower lobes (RLL) and three LLL from normal dogs. Pressure-flow (P-Q) curves were obtained by varying Qpa. With arterial and venous occlusion we measured total, arterial, venous, and middle segment resistances under baseline conditions, after serotonin and histamine, either with or without Qpa and with antegrade and retrograde Qbr. Light microscopy was done postmortem. The slope of the P-Q curve was 33.4 mmHg.l-1.min in the ligated lobes compared with 15.9 in the controls, attributable by the occlusion technique mainly to a rise in arterial resistance (22.4 mmHg.l-1.min compared with 7.4 in the controls) with a small rise in venous resistance. This was explained by significant arterial medial muscle thickening and some loss of LLL volume. The arterial segment was markedly hypersensitive to serotonin, and the venous segment was mildly hypersensitive to histamine compared with controls. The occlusion data also enabled us to model the point of entry of the bronchial circulation into the pulmonary circuit at the precapillary level and to calculate bronchial vascular resistance. We conclude that postobstructive vasculopathy substantially raises pulmonary vascular resistance, mainly upstream from the site of entry of the bronchial circulation. The role of the latter may be to keep it from rising excessively in the segments it perfuses, i.e., the middle and venous ones.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2246149     DOI: 10.1152/jappl.1990.69.3.1022

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  8 in total

Review 1.  The role of CXC chemokines in pulmonary fibrosis.

Authors:  Robert M Strieter; Brigitte N Gomperts; Michael P Keane
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

Review 2.  Chemokines as mediators of angiogenesis.

Authors:  Borna Mehrad; Michael P Keane; Robert M Strieter
Journal:  Thromb Haemost       Date:  2007-05       Impact factor: 5.249

3.  Angiogenesis in the mouse lung.

Authors:  W Mitzner; W Lee; D Georgakopoulos; E Wagner
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

4.  Role of ROS in ischemia-induced lung angiogenesis.

Authors:  Julie Nijmeh; Aigul Moldobaeva; Elizabeth M Wagner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-08-06       Impact factor: 5.464

5.  Bronchial Artery Angiogenesis Drives Lung Tumor Growth.

Authors:  Lindsey Eldridge; Aigul Moldobaeva; Qiong Zhong; John Jenkins; Michael Snyder; Robert H Brown; Wayne Mitzner; Elizabeth M Wagner
Journal:  Cancer Res       Date:  2016-08-28       Impact factor: 12.701

6.  Effector T Cells and Ischemia-Induced Systemic Angiogenesis in the Lung.

Authors:  Qiong Zhong; John Jenkins; Aigul Moldobaeva; Franco D'Alessio; Elizabeth M Wagner
Journal:  Am J Respir Cell Mol Biol       Date:  2016-03       Impact factor: 6.914

7.  Bronchial circulation angiogenesis in the rat quantified with SPECT and micro-CT.

Authors:  Christian Wietholt; David L Roerig; John B Gordon; Steven T Haworth; Robert C Molthen; Anne V Clough
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-02-05       Impact factor: 9.236

8.  Effects of ischemia on lung macrophages.

Authors:  Aigul Moldobaeva; Nico van Rooijen; Elizabeth M Wagner
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.